SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018096
Filing Date
2018-07-31
Accepted
2018-07-31 16:01:24
Documents
50
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20180630.htm 10-Q 1303122
2 EX-10.1 apls-ex101_42.htm EX-10.1 42734
3 EX-10.2 apls-ex102_41.htm EX-10.2 92300
4 EX-31.1 apls-ex311_8.htm EX-31.1 16657
5 EX-31.2 apls-ex312_7.htm EX-31.2 16140
6 EX-32.1 apls-ex321_9.htm EX-32.1 8567
7 EX-32.2 apls-ex322_6.htm EX-32.2 8576
8 GRAPHIC g3mttqnwv4we000002.jpg GRAPHIC 62091
9 GRAPHIC g3mttqnwv4we000003.jpg GRAPHIC 28491
10 GRAPHIC g3mttqnwv4we000001.jpg GRAPHIC 24094
  Complete submission text file 0001564590-18-018096.txt   2993478

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT apls-20180630.xml EX-101.INS 230409
12 XBRL TAXONOMY EXTENSION SCHEMA apls-20180630.xsd EX-101.SCH 26853
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20180630_cal.xml EX-101.CAL 25140
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20180630_def.xml EX-101.DEF 53123
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20180630_lab.xml EX-101.LAB 179893
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20180630_pre.xml EX-101.PRE 126631
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 18981099
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences